Is LogicBio Therapeutics, Inc. a good investment? LogicBio Therapeutics, Inc. (LOGC) is currently trading at 15.15 USD.
Earnings Schedule: LogicBio Therapeutics, Inc. is expected to release its next earnings report on Nov. 3, 2026. The market consensus estimate for Forward EPS is -0.04.
No, it does not currently pay a dividend.
LogicBio Therapeutics, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Nov. 3, 2026. The company currently has a trailing EPS of -1.88.
ContextLogic Holdings Inc. focuses on seeking to develop and grow a de novo business and finance potential future bolt-on acquisitions of assets or businesses. The company was incorporated in 2010 and is headquartered in Oakland, California.
| Split Date | Split Ratio to 1 |
|---|---|
| April 12, 2023 | 1:30 |
Community Discussion